GUAZZONI, GIORGIO FERRUCCIO
 Distribuzione geografica
Continente #
NA - Nord America 24.250
AS - Asia 12.546
EU - Europa 4.407
SA - Sud America 1.870
AF - Africa 708
Continente sconosciuto - Info sul continente non disponibili 275
OC - Oceania 30
Totale 44.086
Nazione #
US - Stati Uniti d'America 23.781
SG - Singapore 8.469
CN - Cina 1.598
BR - Brasile 1.564
VN - Vietnam 1.152
IT - Italia 1.056
FI - Finlandia 790
IE - Irlanda 585
NG - Nigeria 516
DE - Germania 509
FR - Francia 354
HK - Hong Kong 309
CA - Canada 300
GB - Regno Unito 269
SE - Svezia 236
NL - Olanda 204
TR - Turchia 173
IN - India 168
AR - Argentina 117
BD - Bangladesh 113
MX - Messico 83
IL - Israele 66
ZA - Sudafrica 64
JP - Giappone 61
RU - Federazione Russa 61
IQ - Iraq 53
BE - Belgio 52
PK - Pakistan 52
UA - Ucraina 46
VE - Venezuela 43
ID - Indonesia 39
SA - Arabia Saudita 39
EC - Ecuador 38
ES - Italia 38
CL - Cile 36
PL - Polonia 36
CO - Colombia 31
PH - Filippine 29
AU - Australia 26
KE - Kenya 25
MA - Marocco 25
CZ - Repubblica Ceca 24
MY - Malesia 24
UZ - Uzbekistan 24
EG - Egitto 22
RO - Romania 21
AE - Emirati Arabi Uniti 19
TW - Taiwan 17
JO - Giordania 16
NP - Nepal 16
PY - Paraguay 16
DZ - Algeria 15
DO - Repubblica Dominicana 14
LT - Lituania 14
AZ - Azerbaigian 13
CH - Svizzera 12
DK - Danimarca 12
JM - Giamaica 12
LB - Libano 12
TT - Trinidad e Tobago 12
A2 - ???statistics.table.value.countryCode.A2??? 11
IR - Iran 11
MD - Moldavia 11
OM - Oman 11
PE - Perù 11
PS - Palestinian Territory 11
TN - Tunisia 11
AL - Albania 10
HN - Honduras 10
KZ - Kazakistan 10
AT - Austria 9
ET - Etiopia 9
EU - Europa 9
PA - Panama 9
CR - Costa Rica 8
GR - Grecia 8
RS - Serbia 8
BG - Bulgaria 7
PT - Portogallo 7
SY - Repubblica araba siriana 7
TH - Thailandia 7
UY - Uruguay 7
HU - Ungheria 6
NI - Nicaragua 6
SN - Senegal 6
BB - Barbados 5
BO - Bolivia 5
NO - Norvegia 5
GE - Georgia 4
HR - Croazia 4
KG - Kirghizistan 4
LV - Lettonia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
KW - Kuwait 3
LY - Libia 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
AM - Armenia 2
Totale 43.796
Città #
Singapore 4.126
Chandler 3.491
Wilmington 3.479
San Mateo 1.267
The Dalles 1.189
Dallas 1.149
Ashburn 1.111
Ann Arbor 1.014
Shanghai 860
Helsinki 787
San Jose 681
Leawood 604
Dublin 580
Princeton 577
Lawrence 558
Milan 539
Boardman 515
Benin City 513
Ho Chi Minh City 369
New York 367
Fairfield 326
Hanoi 310
Beijing 300
Paris 298
Hong Kong 286
Woodbridge 278
Santa Clara 199
Los Angeles 185
Amsterdam 178
Toronto 170
Rome 150
London 145
Falkenstein 144
Seattle 139
São Paulo 124
San Diego 108
Kocaeli 97
Council Bluffs 84
Norwalk 81
Buffalo 71
Haiphong 69
Da Nang 65
Orem 61
Columbus 58
Rio de Janeiro 53
Phoenix 52
Brooklyn 51
Brussels 51
Chicago 49
Figino 44
Belo Horizonte 43
Houston 40
Miami 38
Pune 37
Montreal 36
Johannesburg 34
Munich 34
Philadelphia 33
Atlanta 29
Manchester 29
Terracina 29
Falls Church 28
Dhaka 27
Mexico City 27
Tokyo 26
Warsaw 26
Charlotte 25
Frankfurt am Main 25
Naples 24
Campinas 23
Des Moines 23
Redmond 23
Curitiba 22
Las Vegas 22
Stockholm 22
Tashkent 22
Turin 22
Brasília 21
Guarulhos 21
Hải Dương 21
Nairobi 21
Monmouth Junction 20
Queens 20
Porto Alegre 19
Biên Hòa 18
Chennai 18
Lawrenceville 18
Salvador 18
Moscow 17
Washington 17
Anaheim 15
Kuala Lumpur 15
Reston 15
San Francisco 15
Boston 14
Cleveland 14
Detroit 14
Hillsboro 14
Jacksonville 14
Mumbai 14
Totale 29.164
Nome #
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY. 725
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. 192
"En Bloc" Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study 186
Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project. 180
186 Indication and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy. An analysis of 5 institutions 154
855 Definition of the Limit of Detection (LoD) for serum isoform [−2]proPSA in patients with recurrent prostate cancer after radical prostatectomy: An analytic study 152
MULTICENTRIC VALIDATION OF PADUA SCORE IN PATIENTS WHO UNDERWENT ROBOTIC PARTIAL NEPHRECTOMY 147
A PHASE 1 SAFETY STUDY OF ONCOFID-P-B ADMINISTERED FOR 12 CONSECUTIVE WEEKS IN BCG UNRESPONSIVE/INTOLERANT PATIENTS WITH BLADDER CARCINOMA IN SITU (CIS): PRELIMINARY RESULTS 144
Accuracy of p2PSA and derivatives (%p2PSA and PHI) in predicting prostate cancer in obese men from a multicenter European study 140
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 139
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project 138
Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer 136
63 Preoperative predictors of positive surgical margins in a contemporary cohort of patients treated with bilateral nerve sparing robot assisted laparoscopic radical prostatectomy 136
A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An Update 134
[-2]PROPSA FOR PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: PRELIMINARY RESULTS FROM AN OBSERVATIONAL COHORT STUDY 133
254 Margin, Ischemia, and Complications (MIC) System to report perioperative outcomes of robot-assisted partial nephrectomy: A European Multicenter Observational Study (EMOS project) 133
-2PROPSA, %-2PROPSA AND PHI (PROSTATE HEALTH INDEX) CORRELATE WITH CANCER AGGRESSIVENESS IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY 132
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 132
54 Safety and efficacy of robot-assisted laparoscopic partial nephrectomy during the learning curve in a high volume urological center 130
[Focal therapy and prostate cancer]. 128
Re: Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance 126
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses 123
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 123
4-DRUG INTRACAVERNOUS THERAPY FOR IMPOTENCE DUE TO CORPOREAL VENOOCCLUSIVE DYSFUNCTION 122
A Critical Analysis of the Actual Role of Minimally Invasive Surgery and Active Surveillance for Kidney Cancer 122
An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in men 122
A MODIFIED PROSTATIC UROLUME-WALLSTENT FOR HEALTHY PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA - A EUROPEAN MULTICENTER STUDY 122
Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature. 120
Holmium laser enucleation of the prostate and holmium laser ablation of the prostate: indications and outcome 116
Prediction of Early and Late Complications after Oral Mucosal Graft Harvesting: Multivariable Analysis from a Cohort of 553 Consecutive Patients 115
A COMPARISON OF TRANSRECTAL HYPERTHERMIA, TRANSURETHRAL THERMOTHERAPY, UROLUME WALLSTENT, AND PROSTATIC SPIRAL FOR BENIGN PROSTATIC HYPERPLASIA PATIENTS AT POOR OPERATIVE RISK 115
Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis 115
The Motion: A Robot is Necessary for Laparoscopic Enucleation of Renal Masses 114
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 113
[-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER. A SINGLE HIGH-VOLUME CENTER EXPERIENCE 113
Robot-assisted and Laparoscopic Repair of Ureteropelvic Junction Obstruction: A Systematic Review and Meta-analysis 111
Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review 111
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) REPLY 110
[The added value of robotic surgery]. 110
HIGHLY-TRAINED DOGS' OLFACTORY SYSTEM FOR DETECTING BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY 108
One-stage bulbar urethroplasty: Retrospective analysis of the results in 375 patients 107
A PROSPECTIVE RANDOMIZED COMPARISON AMONG SWL, PCNL AND RIRS FOR LOWER CALYCEAL STONES LESS THAN 2 CM: A MULTICENTER EXPERIENCE 107
Re: Guazzoni et al.: Oncologic Results of Laparoscopic Renal Cryoablation for Clinical T1a Tumors: 8 Years of Experience in a Single Institution (Urology 2010; 76: 624-629) Reply 107
Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination 107
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence 107
HOW TO SIMPLIFY PATIENT POSITIONING AND PORT PLACEMENT DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) 106
Holmium laser enucleation versus transurethral resection of the prostate. Are histological findings comparable? 106
76 Retroperitoneal and transperitoneal robotic assisted pyeloplasty in adults: Techniques and results 106
Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer 106
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups 105
WIDESPREAD USE OF PROTOCOL-BASED ACTIVE SURVEILLANCE IN PROSTATE CANCER: THE SIURO PRIAS ITA EXPERIENCE 105
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 103
Re: Shift Work and Prostate Cancer Incidence in Industrial Workers: A Historical Cohort Study in a German Chemical Company 103
Assessing the Impact of Ischaemia Time During Partial Nephrectomy 102
DIAGNOSTIC ACCURACY OF [-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER 102
ADJUVANT RADIOTHERAPY HAS A POSITIVE IMPACT ON CANCER-SPECIFIC SURVIVAL OF LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS. RESULTS OF A MATCHED ANALYSIS OF A TWO-INSTITUTION SERIES WITH 703 LYMPH NODE POSITIVE PATIENTS 101
A critical analysis of laser prostatectomy in the management of benign prostatic hyperplasia 101
Pelvic lymph node dissection can be safely omitted in men with a risk of nodal metastases ≤5% based on the Briganti nomogram: Validation of the EAU guidelines reccommendations for nodal dissection based on patient outcome 101
Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study 100
EFFECTIVENESS AND SAFETY OF MULTIDRUG INTRACAVERNOUS THERAPY FOR VASCULOGENIC IMPOTENCE 99
Heterotopic allotransplant of the heart and lungs in the rat. Technical note 99
Body mass index and comorbidities do not affect erectile function or urinary continence recovery after bilateral nerve sparing radical retropubic prostatectomy 98
Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting 98
Laparoscopic nephroureterectomy with resection of the distal ureter and bladder cuff in open surgery: Analysis of the safety and oncological outcomes in an Italian multicentric study 98
ACTIVE SURVEILLANCE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 98
IMPACT OF MINIMALLY INVASIVE APPROACH ON THE PROBABILITY OF EARLY COMPLETE FUNCTIONAL RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY 98
Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European study. 98
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 98
Hypofractionated Tomotherapy Treatment (HTT) in Prostate Cancer Lymph Nodal Relapse Detectedby 11C-Choline PET/CT 97
One-stage circumferential buccal mucosa craft urethroplasty for bulbous stricture repair 97
Ventral Oral Mucosal Onlay Graft Urethroplasty in Nontraumatic Bulbar Urethral Strictures: Surgical Technique and Multivariable Analysis of Results in 214 Patients 97
Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions 96
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) 96
Incidence and predictors of 30-day readmission in patients treated with robot-assisted radical prostatectomy 96
Functional outcomes after robot-assisted radical prostatectomy in young patients (≤ 55 yrs) with prostate cancer: Is surgery perfect in the best candidates? 96
Ga-68 Prostate-specific Membrane Antigen PET/CT for Primary Diagnosis of Prostate Cancer: Complementary or Alternative to Multiparametric MR Imaging 94
EFFECT OF YOHIMBINE-TRAZODONE ON PSYCHOGENIC IMPOTENCE - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY 94
Highly-trained dogs' olfactory system for detecting biochemical recurrence following radical prostatectomy 94
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project 94
Robot-assisted laparoscopic partial nephrectomy with Alf–X Robot on pig model 94
Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study 94
Systematic Review and Meta-analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Prostatectomy 94
Methods and Priorities of Robotic Surgery Training Program 94
Laparoscopic cryoablation of small renal masses: Technique and results after 6-year experience 93
Bone metastases are infrequent in patients with newly diagnosed prostate cancer: Analysis of their clinical and pathologic features 93
The 2011 national comprehensive cancer network guidelines recommendations for pelvic lymph node dissection in prostate cancer patients are not accurate. A plea for renewal 92
WHEN TO PERFORM AN INTRAFASCIAL NERVE SPARING APPROACH WITHOUT COMPROMISING CANCER CONTROL. RESULTS OF A HIGH VOLUME SINGLE SURGEON SERIES 92
An overview of the fifth conference on thermophotovoltaic generation of electricity 92
Early 21st Century Renal Cell Carcinoma A "paradigm shift" 92
Intrafascial bilateral nerve-sparing radical prostatectomy: A comparative functional analysis between open and robotic-assisted video-laparoscopic approaches 92
Prospective analysis of outpatient transrectal interstitial Nd : YAG laser photocoagulation of the prostate in patients with symptomatic benign prostatic hyperplasia 92
Urethral Lift for Benign Prostatic Hyperplasia: A Comprehensive Review of the Literature 92
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 92
INTRAFASCIAL BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: DOES THE ROBOTIC-ASSISTED APPROACH PREDISPOSE TO HIGHER RISK OF POSITIVE SURGICAL MARGINS? IMPORTANCE OF PATIENT SELECTION 92
Predicting Cancer-specific Mortality After Radical Prostatectomy: Still a Long Way To Go 91
TRANSPERITONEAL LAPAROSCOPIC ADRENALECTOMY: SINGLE INSTITUTION 16-YEAR EXPERIENCE 91
The Case for Postoperative PDE-5 Inhibitor Drug Treatment after Radical Prostatectomy 91
MORE EXTENSIVE PELVIC LYMPH NODE DISSECTIONS DURING ROBOTIC ASSISTED RADICAL PROSTATECTOMY ARE ASSOCIATED WITH HIGHER RATES OF PERI-OPERATIVE COMPLICATIONS. RESULTS OF A SINGLE INSTITUTION SERIES 91
Robotic assisted radical prostatectomy in morbidly obese patients: how to create a cost-effective adequate optical trocar 91
Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guerin: experience of a single center 91
Totale 11.675
Categoria #
all - tutte 300.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 300.417


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.711 0 47 59 686 27 29 108 436 257 304 624 134
2022/20238.954 1.243 293 804 965 931 809 9 845 1.738 702 520 95
2023/20243.867 324 546 885 152 132 319 183 242 54 62 306 662
2024/20255.867 161 153 41 69 149 585 280 865 822 1.476 621 645
2025/202614.059 2.030 632 1.020 1.061 332 502 4.981 960 729 777 313 722
2026/20272.095 1.357 738 0 0 0 0 0 0 0 0 0 0
Totale 44.086